Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

428
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
428
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

18
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
18

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT Trial.

Circulation. Cardiovascular interventions·2026
Same author

When Emulation Falls Short: Reaffirming the Role of Randomized Clinical Trials.

Circulation. Population health and outcomes·2026
Same author

Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status.

Kidney international reports·2026
Same author

Standardized processing of explanted hearts after stereotactic arrhythmia radiotherapy (Bio-STAR): a STOPSTORM framework and first human findings.

European heart journal open·2026
Same author

Targeted statin and antiplatelet therapy in women with high-risk cardiovascular disease: how can we overcome sex-based differences?

Expert review of cardiovascular therapy·2026
Same author

Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.

Diabetes, obesity & metabolism·2026

関連する実験動画

Updated: May 5, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.9K

原因不明の栓塞性脳卒中の患者における心房動の発症の予測要因: RE-SPECT ESUS試験の分析

Maria Cecilia Bahit1, Ralph L Sacco2, J Donald Easton3

  • 1INECO Neurociencias, Cardiology Department, Rosario, Argentina (M.C.B.).

Circulation
|October 15, 2021
PubMed
まとめ

高齢,高血圧,高BMIは脳卒中後の心房細動 (AF) を予測する. 糖尿病がないことも AFのリスクを高めます 高リスクの患者を特定することで 再発性脳卒中を予防できます

キーワード:
心房細動血栓性脳卒中ストローク

さらに関連する動画

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K

関連する実験動画

Last Updated: May 5, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.9K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K

科学分野:

  • 心臓病科
  • 神経学
  • 臨床試験

背景:

  • 原因不明の栓塞性脳卒中 (ESUS) の患者は,静かな心房細動 (AF) を患うか,後になって発症する可能性があります.
  • ESUS患者の再発性脳卒中を予防するには,AFの予測要因を特定することが重要です.
  • RE-SPECT ESUS試験は AFの発達予測に関する洞察を提供します.

研究 の 目的:

  • 原因不明の栓塞性脳卒中 (ESUS) の患者における新発性心房細動 (AF) の予測要因を特定する.
  • これらの予測因子と再発性脳卒中リスクとの関係を評価する.
  • ESUS患者におけるAF発達の予測における既存のリスクスコアの有用性を評価する.

主な方法:

  • RE- SPECT ESUS試験では,5390人の患者をランダムにダビガトランまたはアスピリンに分けました.
  • AFの進行をモニタリングし,患者の追跡期間は平均19ヶ月でした.
  • 単変数および多変数回帰分析により,AFの予測要因が特定されました.

主要な成果:

  • 高齢,高血圧,高体量指数,糖尿病の欠如はAFの独立予測因子でした.
  • サブグループ分析では,高齢とNT-proBNPの上昇がAFを予測した.
  • HAVOCとCHA2DS2- VAScのような既存のリスクスコアは,より高いAF発症率と関連していました.

結論:

  • 年齢,高血圧,BMI,糖尿病の状態はESUS後のAFの主要な予測要因です.
  • NT-proBNPレベルは,年齢とともに,有意な予測指標です.
  • 高リスクの人を特定することで 脳卒中を予防するための 集中的な心臓モニタリング戦略を導き出せるのです